Clinical, radiological, histological and molecular characteristics of paediatric epithelioid glioblastoma
- 15 October 2013
- journal article
- research article
- Published by Wiley in Neuropathology and Applied Neurobiology
- Vol. 40 (3), 327-336
- https://doi.org/10.1111/nan.12093
Abstract
Aims A few case series in adults have described the characteristics of epithelioid glioblastoma (e‐GB), one of the rarest variants of this cancer. We evaluated clinical, radiological, histological and molecular characteristics in the largest series to date of paediatric e‐GB. Methods Review of clinical characteristics and therapy, imaging studies and histology was performed in patients younger than 22 years with e‐GB seen at our institution over 15 years. Sequencing of hotspot mutations and fluorescence in situ hybridization of relevant genes were undertaken. Results Median age at diagnosis of six patients was 7.6 years. Tumours originated in the cerebral cortex (n = 2) or diencephalon (n = 4). Three patients presented with acute, massive haemorrhage and three had leptomeningeal dissemination at diagnosis. Paediatric e‐GB had the typical histological characteristics seen in adult tumours. Universal immunoreactivity for INI1 and lack of diverse protein expression were seen in all cases. One tumour had a chromosome 22q loss. Three tumours (50%) harboured a BRAF: p.V600E. One thalamic tumour had an H3F3A p.K27M. All patients received radiation therapy with (n = 3) or without chemotherapy (n = 3). All patients experienced tumour progression with a median survival of 169 days. One patient with nonmetastatic disease had early leptomeningeal progression. Two patients had symptomatic tumour spread outside the central nervous system (CNS) through a ventriculoperitoneal shunt. One additional patient had widespread metastases outside the CNS identified at autopsy. Conclusions Paediatric e‐GBs are rare cancers with an aggressive behaviour that share histological and genetic characteristics with their adult counterparts. BRAF inhibition is a potential treatment for these tumours.This publication has 40 references indexed in Scilit:
- Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomasNature Genetics, 2012
- Targeted Therapy for BRAFV600E Malignant AstrocytomaClinical Cancer Research, 2011
- Atypical Teratoid/Rhabdoid Tumor Arising in a GangliogliomaThe American Journal of Surgical Pathology, 2011
- Rhabdoid glioblastoma in a child: case report and literature reviewBrain Tumor Pathology, 2011
- Oncogenic BRAF Mutation with CDKN2A Inactivation Is Characteristic of a Subset of Pediatric Malignant AstrocytomasCancer Research, 2010
- Phase I and Pharmacokinetic Studies of Erlotinib Administered Concurrently with Radiotherapy for Children, Adolescents, and Young Adults with High-Grade GliomaClinical Cancer Research, 2009
- Malignant Gliomas with Primitive Neuroectodermal Tumor‐like Components: A Clinicopathologic and Genetic Study of 53 CasesBrain Pathology, 2008
- Epithelial and pseudoepithelial differentiation in glioblastoma and gliosarcomaCancer, 2008
- An Integrated Genomic Analysis of Human Glioblastoma MultiformeScience, 2008
- Infiltrative Astrocytomas With Granular Cell Features (Granular Cell Astrocytomas)The American Journal of Surgical Pathology, 2002